Advertisement
Screener

BIOAGE LABS, INC. (BIOA) Market Cap

BIOAGE LABS, INC. (BIOA) Market Cap

  • 2026-09-03: Market Cap $435.79M.
  • 2026-07-31: Market Cap $414.91M.
  • 2026-06-30: Market Cap $1.12B.
  • 2026-05-01: Market Cap $746.36M.

Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.

Available history
2024-09-30 to 2026-09-03
Data captured

Historical Market Cap

DateMarket Cap
2026-09-03$435.79M
2026-07-31$414.91M
2026-06-30$1.12B
2026-05-01$746.36M
2026-03-31$776.32M
2026-03-19$933.75M
2025-12-31$494.63M
2025-10-31$271.42M
2025-09-30$210.8M
2025-08-01$147.7M
2025-06-30$148.06M
2025-05-02$150.21M
2025-03-31$134.8M
2025-03-17$155.59M
2024-12-31$207.57M
2024-10-31$846.03M
2024-09-30$711.29M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Benitec Biopharma Inc. (BNTC)United States$0.337B-10.08
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Emergent BioSolutions Inc. (EBS)United States$0.347B-2.43
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
ENANTA PHARMACEUTICALS INC (ENTA)United States$0.349B-6.72
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Vogenx, Inc. (VOGX)United States$0.355B
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58